Found: 10
Select item for more details and to access through your institution.
Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 368, doi. 10.1634/theoncologist.2014-0250
- By:
- Publication type:
- Article
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2006, v. 20, n. 19, p. 2845, doi. 10.1002/rcm.2668
- By:
- Publication type:
- Article
Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133<sup>+</sup> cells in clear cell renal carcinoma.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 2, p. 126, doi. 10.1096/fba.2019-00071
- By:
- Publication type:
- Article
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 341, doi. 10.1007/s10637-010-9493-4
- By:
- Publication type:
- Article
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 3, p. 481, doi. 10.1007/s10637-009-9367-9
- By:
- Publication type:
- Article
Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
- Published in:
- BJU International, 2021, v. 127, n. 6, p. 628, doi. 10.1111/bju.15409
- By:
- Publication type:
- Article
Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
- Published in:
- BJU International, 2021, v. 127, n. 6, p. 628, doi. 10.1111/bju.15409
- By:
- Publication type:
- Article
Using prognosis to guide early detection and treatment selection in non‐metastatic prostate cancer.
- Published in:
- BJU International, 2019, v. 123, n. 4, p. 562, doi. 10.1111/bju.14637
- By:
- Publication type:
- Article
Using prognosis to guide early detection and treatment selection in non‐metastatic prostate cancer.
- Published in:
- BJU International, 2019, v. 123, n. 4, p. 562, doi. 10.1111/bju.14637
- By:
- Publication type:
- Article
Implementation and yield of upfront genomic profiling in a clinical prostate cancer diagnostic pathway.
- Published in:
- BJU International, 2023, v. 132, n. 5, p. 499, doi. 10.1111/bju.16101
- By:
- Publication type:
- Article